BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23512499)

  • 1. Cardamonin ameliorates insulin resistance induced by high insulin and high glucose through the mTOR and signal pathway.
    Niu P; Zhang Y; Shi D; Chen Y; Deng J
    Planta Med; 2013 Apr; 79(6):452-8. PubMed ID: 23512499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiproliferation of cardamonin is involved in mTOR on aortic smooth muscle cells in high fructose-induced insulin resistance rats.
    Liao Q; Shi DH; Zheng W; Xu XJ; Yu YH
    Eur J Pharmacol; 2010 Sep; 641(2-3):179-86. PubMed ID: 20566415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
    Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
    J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin.
    Takano A; Usui I; Haruta T; Kawahara J; Uno T; Iwata M; Kobayashi M
    Mol Cell Biol; 2001 Aug; 21(15):5050-62. PubMed ID: 11438661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-leucine availability regulates phosphatidylinositol 3-kinase, p70 S6 kinase and glycogen synthase kinase-3 activity in L6 muscle cells: evidence for the involvement of the mammalian target of rapamycin (mTOR) pathway in the L-leucine-induced up-regulation of system A amino acid transport.
    Peyrollier K; Hajduch E; Blair AS; Hyde R; Hundal HS
    Biochem J; 2000 Sep; 350 Pt 2(Pt 2):361-8. PubMed ID: 10947949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetaldehyde promotes rapamycin-dependent activation of p70(S6K) and glucose uptake despite inhibition of Akt and mTOR in dopaminergic SH-SY5Y human neuroblastoma cells.
    Fang CX; Yang X; Sreejayan N; Ren J
    Exp Neurol; 2007 Jan; 203(1):196-204. PubMed ID: 16962100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory Effects of Cardamonin in Ovarian Cancer Cells Are Mediated via mTOR Suppression.
    Chen H; Shi D; Niu P; Zhu Y; Zhou J
    Planta Med; 2018 Nov; 84(16):1183-1190. PubMed ID: 29772587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mTOR inhibition of cardamonin on antiproliferation of A549 cells is involved in a FKBP12 independent fashion.
    Tang Y; Fang Q; Shi D; Niu P; Chen Y; Deng J
    Life Sci; 2014 Mar; 99(1-2):44-51. PubMed ID: 24508654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel PKB/Akt inhibitor, MK-2206, effectively inhibits insulin-stimulated glucose metabolism and protein synthesis in isolated rat skeletal muscle.
    Lai YC; Liu Y; Jacobs R; Rider MH
    Biochem J; 2012 Oct; 447(1):137-47. PubMed ID: 22793019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refeeding and insulin activate the AKT/p70S6 kinase pathway without affecting IRS1 tyrosine phosphorylation in chicken muscle.
    Duchêne S; Métayer S; Audouin E; Bigot K; Dupont J; Tesseraud S
    Domest Anim Endocrinol; 2008 Jan; 34(1):1-13. PubMed ID: 17029674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the mTOR/p70S6K pathway is not involved in the insulin-sensitizing effect of AMPK on cardiac glucose uptake.
    Ginion A; Auquier J; Benton CR; Mouton C; Vanoverschelde JL; Hue L; Horman S; Beauloye C; Bertrand L
    Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H469-77. PubMed ID: 21602475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mTOR partly mediates insulin resistance by phosphorylation of insulin receptor substrate-1 on serine(307) residues after burn.
    Xin-Long C; Zhao-Fan X; Dao-Feng B; Wei D
    Burns; 2011 Feb; 37(1):86-93. PubMed ID: 20594757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of rapamycin treatment on insulin mediated phosphorylation of Akt/PKB and glycogen synthase activity.
    Varma S; Shrivastav A; Changela S; Khandelwal RL
    Exp Cell Res; 2008 Apr; 314(6):1281-91. PubMed ID: 18261725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leucine supplementation in rats induced a delay in muscle IR/PI3K signaling pathway associated with overall impaired glucose tolerance.
    Balage M; Dupont J; Mothe-Satney I; Tesseraud S; Mosoni L; Dardevet D
    J Nutr Biochem; 2011 Mar; 22(3):219-26. PubMed ID: 20558053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATP-mediated protein kinase B Akt/mammalian target of rapamycin mTOR/p70 ribosomal S6 protein p70S6 kinase signaling pathway activation promotes improvement of locomotor function after spinal cord injury in rats.
    Hu LY; Sun ZG; Wen YM; Cheng GZ; Wang SL; Zhao HB; Zhang XR
    Neuroscience; 2010 Sep; 169(3):1046-62. PubMed ID: 20678995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity.
    deGraffenried LA; Friedrichs WE; Russell DH; Donzis EJ; Middleton AK; Silva JM; Roth RA; Hidalgo M
    Clin Cancer Res; 2004 Dec; 10(23):8059-67. PubMed ID: 15585641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells.
    Sekulić A; Hudson CC; Homme JL; Yin P; Otterness DM; Karnitz LM; Abraham RT
    Cancer Res; 2000 Jul; 60(13):3504-13. PubMed ID: 10910062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paradoxical effect of rapamycin on inflammatory stress-induced insulin resistance in vitro and in vivo.
    Yang P; Zhao Y; Zhao L; Yuan J; Chen Y; Varghese Z; Moorhead JF; Chen Y; Ruan XZ
    Sci Rep; 2015 Oct; 5():14959. PubMed ID: 26449763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LY303511 (2-piperazinyl-8-phenyl-4H-1-benzopyran-4-one) acts via phosphatidylinositol 3-kinase-independent pathways to inhibit cell proliferation via mammalian target of rapamycin (mTOR)- and non-mTOR-dependent mechanisms.
    Kristof AS; Pacheco-Rodriguez G; Schremmer B; Moss J
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1134-43. PubMed ID: 15923340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40.
    Vander Haar E; Lee SI; Bandhakavi S; Griffin TJ; Kim DH
    Nat Cell Biol; 2007 Mar; 9(3):316-23. PubMed ID: 17277771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.